DBV Technologies SA (DBVT)
11.43
-0.45
(-3.79%)
USD |
NASDAQ |
Nov 12, 16:00
11.40
-0.03
(-0.26%)
After-Hours: 20:00
DBV Technologies Enterprise Value : 574.77M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 574.77M |
| November 11, 2026 | 603.05M |
| November 10, 2026 | 579.80M |
| November 09, 2026 | 550.89M |
| November 06, 2026 | 513.19M |
| November 05, 2026 | 472.34M |
| November 04, 2026 | 481.14M |
| November 03, 2026 | 491.82M |
| November 02, 2026 | 425.21M |
| October 30, 2026 | 452.86M |
| October 29, 2026 | 503.13M |
| October 28, 2026 | 525.75M |
| October 27, 2026 | 492.76M |
| October 26, 2026 | 483.65M |
| October 23, 2026 | 469.20M |
| October 22, 2026 | 464.80M |
| October 21, 2026 | 461.03M |
| October 20, 2026 | 452.23M |
| October 19, 2026 | 420.18M |
| October 16, 2026 | 425.21M |
| October 15, 2026 | 428.98M |
| October 14, 2026 | 413.90M |
| October 13, 2026 | 423.95M |
| October 12, 2026 | 456.63M |
| October 09, 2026 | 472.34M |
| Date | Value |
|---|---|
| October 08, 2026 | 456.63M |
| October 07, 2026 | 470.45M |
| October 06, 2026 | 483.65M |
| October 05, 2026 | 512.56M |
| October 02, 2026 | 519.47M |
| October 01, 2026 | 560.94M |
| September 30, 2026 | 595.51M |
| September 29, 2026 | 683.56M |
| September 28, 2026 | 688.89M |
| September 25, 2026 | 684.15M |
| September 24, 2026 | 686.52M |
| September 23, 2026 | 720.26M |
| September 22, 2026 | 747.48M |
| September 21, 2026 | 716.11M |
| September 18, 2026 | 730.91M |
| September 17, 2026 | 740.38M |
| September 16, 2026 | 697.77M |
| September 15, 2026 | 695.99M |
| September 14, 2026 | 730.91M |
| September 11, 2026 | 701.32M |
| September 10, 2026 | 767.60M |
| September 09, 2026 | 795.42M |
| September 08, 2026 | 785.36M |
| September 04, 2026 | 797.19M |
| September 03, 2026 | 810.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cellectis SA | 71.36M |
| Akari Therapeutics Plc | 4.334M |
| Bicycle Therapeutics Plc | -280.85M |
| EDAP TMS SA | 142.35M |
| Autolus Therapeutics Plc | 508.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -64.43M |
| Total Expenses (Quarterly) | 64.43M |
| EPS Diluted (Quarterly) | -0.7143 |
| Earnings Yield | -26.44% |
| Normalized Earnings Yield | -26.44 |